⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21136842 | 0.84 | CHRNA7 (0.31) | — | |
| SCHEMBL23962145 | 0.69 | PDE4B (0.33) | — | |
| SCHEMBL4454355 | 0.66 | — | — | |
| SCHEMBL2284513 | 0.66 | — | — | |
| SCHEMBL16889120 | 0.66 | — | — | |
| SCHEMBL23462594 | 0.65 | CHRNA7 (0.35) | — | |
| SCHEMBL14413825 | 0.63 | CHRNA7 (0.34) | — | |
| SCHEMBL10304537 | 0.63 | SIRT2 (0.32) | — | |
| SCHEMBL18848901 | 0.62 | LMNA (0.45) | — | |
| SCHEMBL16885277 | 0.62 | PIK3CD (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3567030-B1 | QUINAZOLINE COMPOUND FOR EGFR INHIBITION | MEDSHINE DISCOVERY INC (CN) | 2022-02-09 | — | — | EP | disclosed |
| WO-2018121758-A1 | QUINAZOLINE COMPOUND FOR EGFR INHIBITION | 南京明德新药研发股份有限公司 | 2018-07-05 | — | — | WO | disclosed |